Investors

Verndari is currently supported by a select group of two dozen “Angel Investors”.

Many Investors have held Senior Executive Positions in the Pharmaceutical Industry, Healthcare Industry and Banking.

Vaccine Vision

A broad family of room temperature stable vaccines self administered via a painless patch...

read more
Featured Article
Featured Team Member

Dr. Peter K. Vogt
Professor, Dept. of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA

Dr. Vogt research is on mechanisms of cancer. He served as a scientific advisor to both Microgenics and Calydon. He is a member of the National Academy of Sciences.

read more